BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 19148987)

  • 1. [Hyperpermeability of the small intestine mucosa after prolonged application of non-steroidal anti-inflammatory drugs in patients with rheumatic diseases].
    Lebedeva VV; Gmoshinskiĭ IV; Mazo VK; Murav'ev IuV
    Eksp Klin Gastroenterol; 2008; (2):16-21. PubMed ID: 19148987
    [No Abstract]   [Full Text] [Related]  

  • 2. Non steroidal anti-inflammatory drugs. Risk factors versus benefits.
    Savvas P; Brooks PM
    Aust Fam Physician; 1991 Dec; 20(12):1726-9, 1732-3. PubMed ID: 1805774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endoscopic study of digestive lesions caused by the use of nonsteroidal anti-inflammatory agents in rheumatic patients].
    van Linthoudt D; Kocher F; Ott H
    Schweiz Med Wochenschr; 1987 Apr; 117(16):604-8. PubMed ID: 3495881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
    Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA
    Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
    [No Abstract]   [Full Text] [Related]  

  • 5. [Free oxygen radicals. Their role in the physiopathology of rheumatic diseases and therapeutic implications].
    Allegrezza Giulietti A; Muti S; Piergiacomi G
    Clin Ter; 1987 Sep; 122(6):445-57. PubMed ID: 2972458
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of endotoxin in inflammatory rheumatic diseases--the effect of nonsteroidal anti-inflammatory agents on intestinal permeability].
    Busch J; Hammer M; Brunkhorst R; Wagener P
    Z Rheumatol; 1988; 47(3):156-60. PubMed ID: 3213262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased intestinal permeability in ankylosing spondylitis--primary lesion or drug effect?
    Morris AJ; Howden CW; Robertson C; Duncan A; Torley H; Sturrock RD; Russell RI
    Gut; 1991 Dec; 32(12):1470-2. PubMed ID: 1773950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs.
    Sugimori S; Watanabe T; Tabuchi M; Kameda N; Machida H; Okazaki H; Tanigawa T; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Oshitani N; Koike T; Higuchi K; Arakawa T
    Digestion; 2008; 78(4):208-13. PubMed ID: 19142000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of non-steroidal anti-inflammatory agents on kidney function in patients with rheumatoid arthritis].
    Dvorkin EB; Murav'ev IuV
    Revmatologiia (Mosk); 1991; (2):28-30. PubMed ID: 1925261
    [No Abstract]   [Full Text] [Related]  

  • 10. [NSAID prescription in patients with rheumatoid arthritis and cardiovascular disease].
    Pavlović R; Curković B; Babić-Naglić D; Kehler T
    Reumatizam; 2006; 53(1):22-4. PubMed ID: 17580545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and functional changes in small intestine in the treatment of osteoarthritis with nonsteroidal antiinflammatory drugs].
    Vakhrushev IaM; Zagrebina EA
    Eksp Klin Gastroenterol; 2010; (3):18-22. PubMed ID: 20499447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-steroidal anti-inflammatory agents increase intestinal permeability].
    Auer IO; Habscheid W; Hiller S; Gerhards W; Eilles C
    Dtsch Med Wochenschr; 1987 Jun; 112(26):1032-7. PubMed ID: 3109868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis.
    Madhok R; MacKenzie JA; Lee FD; Bruckner FE; Terry TR; Sturrock RD
    Q J Med; 1986 Jan; 58(225):53-8. PubMed ID: 3704106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current nonsteroidal anti-inflammatory drug applications for rheumatic diseases.
    Kantor TG
    Prim Care; 1993 Dec; 20(4):955-63. PubMed ID: 8310091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastroduodenal tolerance and clinical effectiveness of therapy with lonazolac-calcium in rheumatic diseases].
    Kullich W; Fromme K; Klein G
    Wien Med Wochenschr; 1996; 146(17):459-64. PubMed ID: 9045528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the effect of therapy with Turganil in 1,240 patients].
    Zgradić I; Popović M; Lasić G
    Med Pregl; 1993; 46(11-12):445-8. PubMed ID: 7997202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine: therapeutic effects in rheumatic diseases.
    Amor B; Dougados M
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):218-23. PubMed ID: 3289207
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent drugs and the rheumatic diseases.
    Huskisson EC
    Rep Rheum Dis; 1974 Oct; (54):1. PubMed ID: 4376254
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of painful soft tissue rheumatic diseases].
    Graml W; Marx-Heep I
    ZFA (Stuttgart); 1982 Nov; 58(33):1847-9. PubMed ID: 6984258
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacotherapy of rheumatic diseases].
    Gaja A; Vykydal M
    Acta Univ Palacki Olomuc Fac Med; 1985; 108():295-300. PubMed ID: 3161288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.